Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 251 entries
View as:

Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT01994473 Org: User:
Start: 10/31/13 End: 12/31/14 Due: 12/31/15

A Trial of Centanafadine Efficacy and Safety in Adults With Attention-deficit/Hyperactivity Disorder and Comorbid Anxiety

Phase: N/A Priority: Normal
NCT ID: NCT06973577 Org: User:
Start: 03/26/25 End: 09/29/27 Due: 09/29/28

A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04030143 Org: User:
Start: 08/01/19 End: 07/08/20 Due: 07/08/21

This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation.

Phase: N/A Priority: Normal
NCT ID: NCT05015673 Org: User:
Start: 06/05/14 End: 05/26/15 Due: 05/26/16

Aripiprazole Oral Acceptability Trial

Phase: N/A Priority: Normal
NCT ID: NCT00101569 Org: User:
Start: 03/31/04 End: 03/31/05 Due: 03/31/06

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03420222 Org: User:
Start: 01/18/18 End: 12/28/18 Due: 12/28/19

Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01423903 Org: User:
Start: 02/28/10 End: 04/30/13 Due: 04/30/14

International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia

Phase: N/A Priority: Normal
NCT ID: NCT02449044 Org: User:
Start: 05/31/04 End: 10/31/09 Due: 10/31/10

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal
NCT ID: NCT03393520 Org: User:
Start: 10/13/17 End: 12/14/23 Due: 12/14/24

Safety Follow-up Study for Subjects With Agitation Associated With Dementia of the Alzheimer's Type Who Previously Participated in a Double-blind Trial of Brexpiprazole or Placebo

Phase: N/A Priority: Normal
NCT ID: NCT02192554 Org: User:
Start: 06/30/14 End: 05/31/17 Due: 05/31/18

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Phase: N/A Priority: Normal
NCT ID: NCT01727726 Org: User:
Start: 12/31/12 End: 11/10/16 Due: 11/10/17

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

Phase: N/A Priority: Normal
NCT ID: NCT04782258 Org: User:
Start: 07/15/22 End: 02/23/28 Due: 02/23/29

A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04100096 Org: User:
Start: 10/17/19 End: 06/27/21 Due: 06/27/22

Aripiprazole in Adolescents With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00102063 Org: User:
Start: 07/31/04 End: 08/31/06 Due: 08/31/07

Substudy of the Accuracy of Ingestible Event Marker (IEM) Detection by the Medical Information Device #1 (MIND1)

Phase: N/A Priority: Normal
NCT ID: NCT02091882 Org: User:
Start: 03/21/14 End: 04/18/14 Due: 04/18/15

A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania

Phase: N/A Priority: Normal
NCT ID: NCT00261443 Org: User:
Start: 09/30/05 End: 10/31/09 Due: 10/31/10

Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05066724 Org: User:
Start: 09/15/21 End: 05/31/22 Due: 05/31/23

Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01418339 Org: User:
Start: 07/27/11 End: 11/06/13 Due: 11/06/14

Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depression Episode

Phase: N/A Priority: Normal
NCT ID: NCT00080314 Org: User:
Start: 01/31/04 End: 10/31/06 Due: 10/31/07

IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT01009840 Org: User:
Start: 05/31/10 End: 03/31/12 Due: 03/31/13

Study Assessing SEP-363856 in Male and Female Volunteers With High or Low Schizotype Characteristics

Phase: N/A Priority: Normal
NCT ID: NCT01972711 Org: User:
Start: 03/31/14 End: 07/31/15 Due: 07/31/16

Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD

Phase: N/A Priority: Normal
NCT ID: NCT04124614 Org: User:
Start: 10/17/19 End: 08/08/23 Due: 08/08/24

A Study of Aripiprazole in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00105196 Org: User:
Start: 03/31/05 End: 03/31/08 Due: 03/31/09

A Phase 3, 12-week, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of 2 Fixed Doses of Brexpiprazole in the Treatment of Alzheimer's Agitation

Phase: N/A Priority: Normal
NCT ID: NCT01862640 Org: User:
Start: 07/11/13 End: 03/15/17 Due: 03/15/18

A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01711034 Org: User:
Start: 06/30/12 End: 12/31/15 Due: 12/31/16